Innovate UK and the Medical Research Council have announced the winners of rounds five and six of Biomedical Catalyst funding.
More than £30 million has been split between 29 winning projects.
The University of Oxford is the lead recipient of two of the fifth-round awards: one to take a vaccine against meningococcal disease to phase I trials and one to develop a gene therapy for Huntington’s disease.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.